<DOC>
	<DOC>NCT01496859</DOC>
	<brief_summary>The Baska mask is a new supraglottic airway device . The investigators would like to assess its performance in setting in which the current standard - LMA device - is being used.</brief_summary>
	<brief_title>Observational Study of Baska Mask, a New Supraglottic Airway Device</brief_title>
	<detailed_description>Our group has performed a number of studies on novel airway devices. In this study we would like to evaluate a new supraglottic airway named Baska mask. We would like to monitor certain parameters (time to and ease of insertion, failure rate, seal pressures, complications etc) as regarding the performance and safety profile of this device. This is a descriptive case series of patients undergoing airway management under general anaesthesia.</detailed_description>
	<criteria>Written informed Consent No relevant drug allergies Bodymass index (BMI) 2035 Age 1865 Nonurgent surgery of planned duration 02 hrs Inability of patient/parent to understand or consent for the trial NonEnglish speakers Neck pathology Previous or anticipated problems with the upper airway or upper GI tract (reflux, hiatus hernia, oropharyngeal tumour, upper respiratory tract infection in the last 10 days etc) BMI &gt;35 Expected Difficult airway Live Pregnancy Increased risk for Gastric Aspiration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Baska mask</keyword>
	<keyword>supraglottic airway</keyword>
	<keyword>airway management</keyword>
</DOC>